[{"Assets_0_FY_USD":70615000000.0,"CommonStockDividendsPerShareDeclared_4_FY_USD":1.36,"EarningsPerShareBasic_1_FY_USD":-11.41,"EarningsPerShareBasic_4_FY_USD":-16.26,"EarningsPerShareDiluted_1_FY_USD":-11.41,"EarningsPerShareDiluted_4_FY_USD":-16.26,"NetCashProvidedByUsedInOperatingActivitiesConverted_4_FY_USD":3507000000.0,"NetIncomeLossConverted_4_FY_USD":-16449000000.0,"RevenuesConverted_1_FY_USD":5459000000.0,"RevenuesConverted_4_FY_USD":22385000000.0,"StockholdersEquity_0_FY_USD":17359000000.0,"StockholdersEquityConverted_0_FY_USD":18745000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":1016000000.0,"Ticker":"TEVA","CIK":"818686","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","OfficialName":"Teva Pharmaceutical Industries Limited American Depositary Shares","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"11303387401.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20180212"}]